Our findings from TDP-43 genetic interaction analyses and pharmacological validation experiments indicate that TDP-43 and its interactors SDHA and VDAC3 play important roles in the inflammatory activation of astrocytes; consequently, they may also be associated with the pathological features of ALS and FTD. Here, TARDBP is linked to frontotemporal dementia.